Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 9/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | IFNAR1 | P17181 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30949223 | 0.88 | LIPG (0.50) | SLC6A4SLC6A2SLC6A3LTA4HLIPG | |
| SCHEMBL30949224 | 0.88 | LIPG (0.50) | SLC6A4SLC6A2SLC6A3LTA4HLIPG | |
| SCHEMBL902105 | 0.88 | LIPG (0.50) | SLC6A4SLC6A2SLC6A3LTA4HLIPG | |
| Anthracene SCHEMBL1506819 | 0.79 | LIPG (0.43) | SLC6A4SLC6A2SLC6A3LTA4HLIPG | |
| SCHEMBL31265560 | 0.75 | SLC6A4 (0.57) | SLC6A4SLC6A2SLC6A3LTA4HKDM4E | |
| SCHEMBL8016874 | 0.75 | SLC6A4 (0.57) | SLC6A4SLC6A2SLC6A3LTA4HKDM4E | |
| SCHEMBL13287109 | 0.73 | LIPG (0.48) | SLC6A4LIPGKDM4EPKM | |
| SCHEMBL668320 | 0.72 | SLC6A4 (0.33) | SLC6A4SLC6A2SLC6A3LTA4HLIPG | |
| SCHEMBL26082831 | 0.72 | CA12 (0.40) | LIPGMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL15698106 | 0.72 | RIPK1 (0.42) | LIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140194383-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | CORNELL UNIVERSITY (US) | 2014-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194383-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | CALCOCO2, MDN1, MBNL1 | SLC6A4 4761/4885SLC6A2 4846/4885SLC6A3 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.